PBPIA
EXAI

Pivotal bioVenture Partners Investment Advisor’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Pivotal bioVenture Partners Investment Advisor’s Portfolio EXAI Stock Details EXAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-770,500
Closed -$3.76M – 12
2024
Q3 		$3.76M Hold
770,500
– – 2.23% 7
2024
Q2 		$3.93M Hold
770,500
– – 3.02% 5
2024
Q1 		$4.41M Hold
770,500
– – 2.83% 7
2023
Q4 		$4.94M Hold
770,500
– – 1.25% 9
2023
Q3 		$3.48M Hold
770,500
– – 1.39% 9
2023
Q2 		$4.56M Sell
770,500
-1,785
-0.2% -$10.9K 1.5% 9
2023
Q1 		$4.09M Hold
772,285
– – 1.69% 9
2022
Q4 		$4.12M Hold
772,285
– – 1.79% 7
2022
Q3 		$6.34M Hold
772,285
– – 2.32% 7
2022
Q2 		$8.41M Hold
772,285
– – 4.24% 7
2022
Q1 		$11.1M Hold
772,285
– – 5.26% 5
2021
Q4 		$15.3M Buy
+772,285
New +$16.2M 6.38% 4

Other funds holding EXAI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's EXAI Position: Q4 2024 in Review

Pivotal bioVenture Partners Investment Advisor sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2024, closing a stake of 770,500 shares — an estimated $3.76M sold.

Pivotal bioVenture Partners Investment Advisor first reported a position in EXAI in Q4 2021 and held it in 12 quarters. The position peaked at $15.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds EXAI as of Q4 2024.

  • Pivotal bioVenture Partners Investment Advisor reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Pivotal bioVenture Partners Investment Advisor sold 770,500 Exscientia Plc American Depositary Shares shares in Q4 2024, an estimated $3.76M.
  • Pivotal bioVenture Partners Investment Advisor first reported a position in Exscientia Plc American Depositary Shares in Q4 2021 and held it in 12 quarters.
  • Pivotal bioVenture Partners Investment Advisor's Exscientia Plc American Depositary Shares position peaked at $15.3M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2024.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q4 2024, filed 13 Feb 2025.